Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23395593)

1.

Taxanes: still a major weapon in the armamentarium against prostate cancer.

Loriot Y, Fizazi K.

Eur Urol. 2013 Jun;63(6):983-5. doi: 10.1016/j.eururo.2013.01.016. Epub 2013 Jan 21. No abstract available.

PMID:
23395593
2.

New taxane treats advanced prostate cancer.

Thompson CA.

Am J Health Syst Pharm. 2010 Aug;67(15):1220. doi: 10.2146/news100052. No abstract available.

PMID:
20651307
3.

[Combination chemotherapy with cis-platinum and ifosfamide for hormone unresponsive prostate cancer].

Maki Y, Tsushima T, Nasu Y, Kumon H, Ohmori H, Tanahashi T, Nanba K, Ohashi T, Kondo K, Saika T, Asahi T, Saegusa M, Ozaki Y, Yamashita Y, Katayama Y, Kobuke M, Uno S, Ochi J, Kobashi K, Hata K.

Nihon Hinyokika Gakkai Zasshi. 1998 Jul;89(7):657-64. Review. Japanese.

4.

Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experience.

Kamradt JM, Smith DC, Pienta KJ.

Urol Clin North Am. 1999 May;26(2):333-40.

PMID:
10361556
5.

Docetaxel improves survival in metastatic androgen-independent prostate cancer.

Price N.

Clin Prostate Cancer. 2004 Jun;3(1):18-20. No abstract available.

PMID:
15279685
6.

Abiraterone and increased survival in metastatic prostate cancer.

Berruti A, Pia A, Terzolo M.

N Engl J Med. 2011 Aug 25;365(8):766; author reply 767-8. doi: 10.1056/NEJMc1107198#SA1. No abstract available.

PMID:
21864182
7.
8.

Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer.

Shioi K, Yoshida M, Sakai N.

Int J Urol. 2003 Nov;10(11):625-6.

PMID:
14633092
9.

Primary cutaneous nocardiosis caused by Nocardia beijingensis in an immunocompromised patient with chemotherapy for advanced prostate cancer.

Ohmori S, Kobayashi M, Yaguchi T, Nakamura M.

J Dermatol. 2012 Aug;39(8):740-1. doi: 10.1111/j.1346-8138.2011.01411.x. Epub 2011 Nov 12. No abstract available.

PMID:
22077499
10.

FDA approves prostate cancer treatment that inhibits testosterone synthesis.

Thompson CA.

Am J Health Syst Pharm. 2011 Jun 1;68(11):960. doi: 10.2146/news110034. No abstract available.

PMID:
21593221
11.

[Prostate antigen as a tumor marker of prostate cancer: (2). Changes of prostate antigen values during anti-cancer chemotherapy].

Kuriyama M, Takeuchi T, Shinoda I, Okano M, Fujimoto Y, Fujihiro S, Nishiura T, Murphy GP, Chu TM.

Nihon Gan Chiryo Gakkai Shi. 1984 Dec 20;19(10):2230-8. Japanese. No abstract available.

PMID:
6085338
12.
13.

Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.

Di Lorenzo G, Autorino R, De Laurentiis M, Bianco R, Lauria R, Giordano A, De Sio M, D'Armiento M, Bianco AR, De Placido S.

Tumori. 2003 Jul-Aug;89(4):349-60. Review.

PMID:
14606635
14.

[New treatment approach to hormone-refractory prostate carcinoma].

Rexer H.

Urologe A. 2007 Jul;46(7):786-8. German. No abstract available.

PMID:
17598082
15.
16.

Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail?

Bellmunt J.

Eur Urol. 2009 Jun;55(6):1310-2. doi: 10.1016/j.eururo.2008.08.065. Epub 2008 Sep 2. No abstract available.

PMID:
18778888
17.

Is chemotherapy the standard for asymptomatic androgen-independent prostate cancer?

Nabhan C.

J Clin Oncol. 2008 May 10;26(14):2413-4; author reply 2414-5. doi: 10.1200/JCO.2008.16.6124. No abstract available.

18.

[Pathomorphosis of prostatic cancer after regional endolymphatic polychemotherapy].

Danil'chenko SA, Shlopov VG, Serniak PS, Geev IuV.

Vrach Delo. 1986 Jun;(6):77-80. Russian. No abstract available.

PMID:
3750969
19.

[Combined treatment of metastatic hormone-resistant prostate cancer].

Kaprin AD, Gafanov RA, Al'bitskiń≠ IA, Fastovets SV.

Vopr Onkol. 2009;55(4):477-9. Russian. No abstract available.

PMID:
19947375
20.

Oral chemotherapy in the treatment of hormone-refractory prostate cancer.

Pienta KJ, Kamradt JM, Smith DC.

Drugs. 1999;58 Suppl 3:127-31. Review.

PMID:
10711851
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk